These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9272278)

  • 1. Treatment with GAD65 or BSA does not protect against diabetes in BB rats.
    Petersen JS; Mackay P; Plesner A; Karlsen A; Gotfredsen C; Verland S; Michelsen B; Dyrberg T
    Autoimmunity; 1997; 25(3):129-38. PubMed ID: 9272278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mice.
    Petersen JS; Karlsen AE; Markholst H; Worsaae A; Dyrberg T; Michelsen B
    Diabetes; 1994 Dec; 43(12):1478-84. PubMed ID: 7958502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.
    Plesner A; Worsaae A; Dyrberg T; Gotfredsen C; Michelsen BK; Petersen JS
    J Autoimmun; 1998 Aug; 11(4):335-41. PubMed ID: 9776711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GAD65 and insulin B chain peptide (9-23) are not primary autoantigens in the type 1 diabetes syndrome of the BB rat.
    Bieg S; Hanlon C; Hampe CS; Benjamin D; Mahoney CP
    Autoimmunity; 1999; 31(1):15-24. PubMed ID: 10593565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.
    Kim J; Richter W; Aanstoot HJ; Shi Y; Fu Q; Rajotte R; Warnock G; Baekkeskov S
    Diabetes; 1993 Dec; 42(12):1799-808. PubMed ID: 8243826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus.
    Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R
    Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice.
    Elliott JF; Qin HY; Bhatti S; Smith DK; Singh RK; Dillon T; Lauzon J; Singh B
    Diabetes; 1994 Dec; 43(12):1494-9. PubMed ID: 7525393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet cell membrane antigens activate diabetogenic CD4+ T-cells in the BB/Wor rat.
    Ellerman KE; Like AA
    Diabetes; 1999 May; 48(5):975-82. PubMed ID: 10331400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes.
    Ujihara N; Daw K; Gianani R; Boel E; Yu L; Powers AC
    Diabetes; 1994 Aug; 43(8):968-75. PubMed ID: 8039604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive monoclonal antibody-based sandwich ELISA for determination of the diabetes-associated autoantigen glutamic acid decarboxylase GAD65.
    Schlosser M; Hahmann J; Ziegler B; Augstein P; Ziegler M
    J Immunoassay; 1997 Nov; 18(4):289-307. PubMed ID: 9358337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice.
    Tisch R; Liblau RS; Yang XD; Liblau P; McDevitt HO
    Diabetes; 1998 Jun; 47(6):894-9. PubMed ID: 9604865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.
    Geng L; Solimena M; Flavell RA; Sherwin RS; Hayday AC
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10055-60. PubMed ID: 9707599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase.
    Hagopian WA; Michelsen B; Karlsen AE; Larsen F; Moody A; Grubin CE; Rowe R; Petersen J; McEvoy R; Lernmark A
    Diabetes; 1993 Apr; 42(4):631-6. PubMed ID: 8454115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase.
    Jun HS; Chung YH; Han J; Kim A; Yoo SS; Sherwin RS; Yoon JW
    Diabetologia; 2002 May; 45(5):668-76. PubMed ID: 12107747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential detection of rat islet and brain glutamic acid decarboxylase (GAD) isoforms with sequence-specific peptide antibodies.
    Li L; Jiang J; Hagopian WA; Karlsen AE; Skelly M; Baskin DG; Lernmark A
    J Histochem Cytochem; 1995 Jan; 43(1):53-9. PubMed ID: 7822765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-reactive autoantibodies in BB/d rats do not recognize glutamic acid decarboxylase.
    Davenport C; Lovell H; James RF; Todd I
    Clin Exp Immunol; 1995 Jul; 101(1):127-35. PubMed ID: 7621582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4.
    Worsaae A; Hejnaes K; Moody A; Ludvigsson J; Pociot F; Lorenzen T; Dyrberg T
    Autoimmunity; 1995; 22(3):183-9. PubMed ID: 8734572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide.
    Chen SL; Whiteley PJ; Freed DC; Rothbard JB; Peterson LB; Wicker LS
    J Autoimmun; 1994 Oct; 7(5):635-41. PubMed ID: 7840855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P; Rivereau AS; Granier C; Haertlé T; Martignat L
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.